Squamous cell carcinoma
The Journal of Family Practice. 2023 July;72(6):E13-E15 | doi: 10.12788/jfp.0644
July 25, 2023|Family Medicine
Author and Disclosure Information
The risk for SCC is increased in immunocompromised patients,2 especially those with HPV.10
The prevalence of SCC in those with HS is approximately 4.6%. The chronic inflammation and irritation from HS in association with other risk factors such as tobacco use may contribute to the malignant transformation to SCC.26
Health disparity highlight
- The risk for metastasis from SCC is 20% to 40% in Black patients vs 1% to 4% in White patients.4,6,27
- Penile SCC was associated with a lower overall survival rate in patients of African descent.20,21
- The increased morbidity and mortality from SCC in patients with skin of color may be attributed to delays in diagnosis and treatment as well as an incomplete understanding of tumor genetics.4,6,18
ACKNOWLEDGMENT
The authors thank Elyse Gadra (Philadelphia, Pennsylvania) for assistance in the preparation of this manuscript.
